Vaccine and Tamiful USELESS against "Blood Lung Flu" (D225G mutation), more mutations expected

EARL NASH

The inconvenient truth for Big Pharma and Donald Rumsfeld is that the lethal "Blood Lung Flu," the D225G strain, is spreading and is resistant to both the H1N1 Swinie Flu vaccine and Tamiflu..

 
 
Lung hemorrhaging is being caused by a swine flu mutation that has been reported in China, Norway, France, and the Ukraine as having a receptor binding domain of D225G. In the United States, there has been a report of fatalities in patients with hemorrhaged lungs, but the mutation has not been confirmed.

Tamiflu-resistant H1N1 mutation
A strain of H1N1 that is resistant to Tamiflu, an antiviral medication, has been found worldwide. Clusters occurred in North Carolina and Wales. One case of H1N1 found in France with the D225G designation was also resistant to Tamiflu.

Swine flu mutation combinations
To date, the H1N1 mutations in the Ukraine have included bleeding in the lungs and resistance to the vaccine, and a case in France included bleeding in the lungs and resistance to antiviral treatment. The common factor appears to be the severe symptom caused by D225G.

The World Health Organization has reported that global deaths from the H1N1 virus have increased by 1000 in the past week. At the same time, the H1N1 virus is mutating, with each mutation causing different effects in patients, and combining in some cases. The national medical laboratory in Britain reported that the H1N1 vaccine would probably not be effective against the variant of the swine flu virus found in the Ukraine flu outbreak. This variant, in which the virus uses D225G as a receptor binding domain, causes bleeding in the lungs. Another H1N1 mutation results in the resistance to treatment with antiviral medication.

http://www.examiner.com/x-29228-LA-Health-Technology-Examiner~y2009m11d28-H1N1-deaths-increase-as-mutations-combine--vaccine--antiviral-resistant-lung-hemorrhaging-virus

Former Defense Secretary, Donald Rumsfeld, served on the Board of Directors of Gilead corporation, the owner of the Tamiflu patent; reportedly, Mr. Rumsfeld is a major stockholder in the company.Ukraineas having a receptor binding domain of D225G. In the United States, there has been a report of fatalities in patients with hemorrhaged lungs, but the mutation has not been confirmed.

Tamiflu-resistant H1N1 mutation

A strain of H1N1 that is resistant to Tamiflu, an antiviral medication, has been found worldwide. Clusters occurred in North Carolina and Wales. One case of H1N1 found in France with the D225G designation was also resistant to Tamiflu.

Swine flu mutation combinations

To date, the H1N1 mutations in the Ukraine have included bleeding in the lungs and resistance to the vaccine, and a case in France included bleeding in the lungs and resistance to antiviral treatment. The common factor appears to be the severe symptom caused by D225G.